Staff Reports
What Do Drug Monopolies Cost Consumers in Developing Countries?
December 2011 Number 530
JEL classification: D4, F13, L1, L65, O34

Author: Rebecca Hellerstein

This paper quantifies the effects of drug monopolies and low per-capita income on pharmaceutical prices in developing economies using the example of the antiretroviral drugs (ARVs) used to treat HIV.

Available only in PDF pdf  11 pages / 141 kb
For a published version of this report, see Rebecca Hellerstein, "What Do Drug Monopolies Cost Consumers in Developing Countries?" Economics Letters 116, no. 1 (July 2012): 108-111.
E-mail Alerts
By continuing to use our site, you agree to our Terms of Use and Privacy Statement. You can learn more about how we use cookies by reviewing our Privacy Statement.   Close